pantoprazole has been researched along with Thromboembolism, Venous in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, BB | 1 |
| Thabane, L | 1 |
| Heels-Ansdell, D | 1 |
| Dionne, JC | 1 |
| Binnie, A | 1 |
| Tsang, J | 1 |
| Guyatt, G | 1 |
| Ahmed, A | 1 |
| Lauzier, F | 1 |
| Deane, A | 1 |
| Arabi, Y | 1 |
| Marshall, J | 1 |
| Zytaruk, N | 1 |
| Saunders, L | 1 |
| Finfer, S | 1 |
| Myburgh, J | 1 |
| Muscedere, J | 1 |
| English, S | 1 |
| Ostermann, M | 1 |
| Hardie, M | 1 |
| Knowles, S | 1 |
| Cook, D | 1 |
1 trial available for pantoprazole and Thromboembolism, Venous
| Article | Year |
|---|---|
Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial.
Topics: Cohort Studies; COVID-19; Critical Illness; Gastrointestinal Hemorrhage; Humans; Pantoprazole; Proto | 2023 |